Showing results (131-140 of 311) with videos related to
Sort By:
Pageof 32
Neurogenetics|June 19, 2012
Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's diseaseEva C Schulte, Brit Mollenhauer, Alexander Zimprich, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2016
Validation of conversion between mini-mental state examination and montreal cognitive assessmentMichael Lawton, Meike Kasten, Margaret T May, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 5, 2024
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical PracticeTiago F Outeiro, Lorraine V Kalia, Erwan Bezard, et al.Neurology|May 11, 2016
Monitoring of 30 marker candidates in early Parkinson disease as progression markersBrit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.Journal of Neurology|July 12, 2015
Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJDFranc Llorens, Niels Kruse, Matthias Schmitz, et al.Parkinsonism & Related Disorders|February 21, 2021
Clinically relevant copy-number variants in exome sequencing data of patients with dystoniaMichael Zech, Sylvia Boesch, Matej Škorvánek, et al.Alzheimer'S Research & Therapy|July 29, 2017
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementiaDavide Chiasserini, Leonardo Biscetti, Paolo Eusebi, et al.Proceedings of the National Academy of Sciences of the United States of America|August 2, 2008
GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synucleinClemens R Scherzer, Jeffrey A Grass, Zhixiang Liao, et al.Cold Spring Harbor Molecular Case Studies|September 29, 2018
A unique de novo gain-of-function variant in CAMK4 associated with intellectual disability and hyperkinetic movement disorderMichael Zech, Daniel D Lam, Sandrina Weber, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 12, 2021
Cerebrospinal α-Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal CohortNour K Majbour, Ilham Y Abdi, Mohammed Dakna, et al.Pageof 32